Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Location of a High Affinity Zn2+ Binding Site in the Channel of α1β1 γ-Aminobutyric AcidA Receptors

Jeffrey Horenstein and Myles H. Akabas
Molecular Pharmacology May 1998, 53 (5) 870-877;
Jeffrey Horenstein
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Myles H. Akabas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Zn2+ inhibits currents through γ-aminobutyric acid (GABA)A receptors. Its affinity depends on the subunit composition; α1β1 receptors are inhibited with high affinity (IC50 = 0.54 μm). We sought to identify the residues that form this high affinity Zn2+ binding site. β1His267 aligns with α1Ser272, a residue near the extracellular end of the M2 membrane-spanning segment that we previously demonstrated to be exposed in the channel. The Zn2+ affinity of α1β1 H267S was reduced by 300-fold (IC50 = 161 μm). Addition of a histidine at the aligned position in α1 creates a receptor, α1S272Hβ1, that should have five channel-lining histidines; the Zn2+ affinity was increased 20-fold (IC50 = 0.025 μm). Shifting the position of the histidine from the β1 subunit to the aligned position in α1 with the two mutants α1S272Hβ1H267S reduced the affinity (IC50 = 26 μm) compared with wild-type. We infer that the high affinity Zn2+ binding site involves β1His267 from at least two subunits. For two histidines to interact with a Zn2+ ion, the α carbons must be separated by <13 Å. This limits the separation of the subunits and provides a constraint on the possible quaternary structures of the channel. The ability of a divalent cation to penetrate from the extracellular end of the channel to β1His267 implies that the charge-selectivity filter, the structure that discriminates between anions and cations, is located at a more cytoplasmic position than β1His267; this is consistent with our previous work that showed that positively charged sulfhydryl-specific reagents reacted with an engineered cysteine residue as cytoplasmic as α1T261C.

Footnotes

  • Send reprint requests to: Dr. Myles Akabas, Center for Molecular Recognition, Columbia University, 630 West 168th Street, Box 7, New York, NY 10032. E-mail: ma14{at}columbia.edu

  • This work was supported in part by National Institutes of Health Grants NS30808 and DK51794. M.H.A. is the recipient of an Established Scientist Award from the American Heart Association, New York City Affiliate.

  • A preliminary report of this work has appeared in abstract form [Horenstein J and Akabas MH (1997) Soc Neurosci Abstr23:112]. While preparing the manuscript, we were informed of a preliminary report describing similar results of mutation of the aligned residue in the β3 subunit, β3His292A [Wooltorton JRA, McDonald BJ, Moss SJ, and Smart TG (1997) Br J Pharmacol122(suppl):38P]. A full version of this work was subsequently published in J Physiol (Lond)505:633–640 (1997).

  • Abbreviations:
    GABAA
    γ-aminobutyric acid type A receptor
    ACh
    acetylcholine
    HEPES
    4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
    CFFR
    Ca2+-free frog Ringer’s solution
    GABA
    γ-aminobutyric acid
    MTS
    methanethiosulfonate
    MTSES−
    methanethiosulfonate ethylsulfonate
    MTSET+
    methanethiosulfonate ethyltrimethylammonium
    pCMBS
    p-chloromercuribenzenesulfonate
    • Received November 10, 1997.
    • Accepted January 16, 1998.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology: 53 (5)
Molecular Pharmacology
Vol. 53, Issue 5
1 May 1998
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Location of a High Affinity Zn2+ Binding Site in the Channel of α1β1 γ-Aminobutyric AcidA Receptors
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Location of a High Affinity Zn2+ Binding Site in the Channel of α1β1 γ-Aminobutyric AcidA Receptors

Jeffrey Horenstein and Myles H. Akabas
Molecular Pharmacology May 1, 1998, 53 (5) 870-877;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

Location of a High Affinity Zn2+ Binding Site in the Channel of α1β1 γ-Aminobutyric AcidA Receptors

Jeffrey Horenstein and Myles H. Akabas
Molecular Pharmacology May 1, 1998, 53 (5) 870-877;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Nelfinavir and PXR
  • P2X7 Positive Modulator Structure-Activity Relationship
  • Predicting Drug Interactions with ENT1 and ENT2
Show more Article

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics